药物释放,捕获效率,和药物载荷能力的纳米粒子 (SLNs) 载荷的固体脂质纳米粒子 (SLNs)
Hadi Valizadeh1, Gity Mirzaei2, Allahveirdy Arjmand3
1Drug Applied Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
Anti-cancer agents in medicinal chemistry
|January 9, 2026
概括
固体脂质纳米颗粒 (SLNs) 通过提高药物载荷能力 (DLC%) 和捕获效率 (EE%) 来改善癌症治疗. 优化SLN配方是控制Taxane输送和减少副作用的关键.
科学领域:
- 制药纳米技术 制药纳米技术
- 药物输送系统 药物输送系统
- 癌症治疗方法 癌症治疗方法
背景情况:
- 固体脂质纳米颗粒 (SLN) 是癌症治疗的先进载体,旨在减轻常规抗癌药物的全身毒性和非特异性分布.
- 抗癌剂的重要类别 - - 塔克森,越来越多地被配制成纳米脂质配方 (NLF),以提高其治疗效果.
研究的目的:
- 系统地审查影响TAXANE装载SLN的捕获效率 (EE%) 和药物载荷能力 (DLC%) 的因素.
- 探索影响着纳载荷SLN控制药物释放特征的关键参数.
- 为优化SLN配方提供更新的视角,用于增强癌症治疗.
主要方法:
- 一个叙述的现有文学药物纳米技术和SLN配方的叙事审查.
- 分析影响EE%的配方变量,包括脂类型,药物特性,表面活性剂和合物.
- 检查影响药物释放的参数,如颗粒大小,共载药物,脂类型,表面修饰剂和环境条件 (pH).
主要成果:
- EE%和DLC%受到药物脂质矩阵特性和表面活性剂选择 (例如Poloxamer,Tween-80) 的显著影响.
- 表面修改 (例如,氨酸,PEGylation) 可以降低EE%,但可以增强目标释放.
- 纳入特定化合物或共同加载可以减缓药物释放,而siRNA可以加速它;pH和脂类型也调节释放率.
结论:
- 配方和环境因素对TAXANE载入的SLN的EE%,DLC%和药物释放行为产生重大影响.
- 了解这些变量对于开发用于癌症治疗的有效和稳定的纳米脂质配方至关重要.
- 这个领域需要持续关注纳米医学在瘤学方面的进步.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
183
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
183
Bioavailability Enhancement: Drug Solubility Enhancement
212
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
212
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
193
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
193
Tissue-Drug Binding: Localization of Drugs and its Significance
388
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
388
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K


